Jonathan Silverstein's Net Worth
$622 Million
Who is Jonathan Silverstein?
Jonathan Silverstein has an estimated net worth of $622 Million. This is based on reported shares across multiple companies, which include AVEDRO INC, RHYTHM PHARMACEUTICALS, INC., INSULET CORP, Relypsa Inc, GLAUKOS Corp, INTERCEPT PHARMACEUTICALS INC, Arcutis Biotherapeutics, Inc., resTORbio, Inc., scPharmaceuticals Inc., AVANIR PHARMACEUTICALS, Roka BioScience, Inc., Audentes Therapeutics, Inc., NxStage Medical, Inc., and LIFECELL CORP.
SEC CIK
Jonathan Silverstein's CIK is 0001171005
Past Insider Trading and Trends
2013 was Jonathan Silverstein's most active year for acquiring shares with 15 total transactions. Jonathan Silverstein's most active month to acquire stocks was the month of June. 2015 was Jonathan Silverstein's most active year for disposing of shares, totalling 49 transactions. Jonathan Silverstein's most active month to dispose stocks was the month of February. 2012 saw Jonathan Silverstein paying a total of $26,000,010.00 for 12,664,479 shares, this is the most they've acquired in one year. In 2014 Jonathan Silverstein cashed out on 31,227,436 shares for a total of $77,167,894.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AVEDRO INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.24M |
—
|
—
|
0
|
Nov 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| +2,681.91% | 4.09M |
—
|
—
| 4.24M |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $47.935
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INSULET CORP (PODD) Snapshot price: $200.06
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.57M |
—
|
—
| 1.57M |
May 15 - May 18
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Relypsa Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 9.94M |
$7.16 | -$300,102.00 | 9.94M |
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GLAUKOS Corp (GKOS) Snapshot price: $94.8625
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -36.45% | -836.50K |
$31.81 | -$26,787,191.74 | 1.46M |
Mar 2 - Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
| -9.62% | -580.20K |
$38.78 | -$22,472,822.20 | 5.45M |
Aug 31 - Sep 5
| |||
Form 4
| -6.38% | -325.00K |
$38.05 | -$12,326,042.80 | 4.77M |
Aug 15 - Aug 17
| |||
Form 4
| -4.91% | -382.54K |
$45.49 | -$17,339,215.44 | 7.4M |
Mar 10 - Mar 14
| |||
Form 4
| -2.56% | -55.77K |
$47.05 | -$2,624,072.60 | 2.12M |
Mar 3
| |||
Form 4
| -4.17% | -292.94K |
$33.71 | -$9,869,285.26 | 6.73M |
Aug 10 - Aug 12
| |||
Form 4
| -14.67% | -425.00K |
$30.59 | -$13,000,750.00 | 2.47M |
Aug 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 4
| +100.55% | 2.9M |
$18.00 | -$211,212.00 | 5.78M |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||